Study of sentinel node detection in recurrent vulvar cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests whether a special dye injection can reliably find the first lymph node that might contain cancer in women whose vulvar cancer has come back for the first time. It aims to help doctors know if the cancer has spread without removing many lymph nodes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- This is the first time your vulvar cancer has come back after treatment.
- The cancer is a single area (not multiple spots) on the vulva.
- The tumor is 4 centimeters (about 1.5 inches) or smaller.
- The tumor does not involve the urethra, vagina, or anus.
- The cancer has not spread to the groin lymph nodes or other parts of your body.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to find and remove the first lymph node that might contain cancer cells in women with large or recurrent vulvar cancer. It uses a special dye to guide the surgeon, which may help improve staging and reduce side effects.
This Phase 2 study looks at how vulvar squamous cell cancer (SCC) spreads to the sentinel lymph node, and how findings may guide treatment. It focuses on specific early-stage tumor features and requires that cancer is found in the sentinel lymph node.
This trial tests a new optical method using a dye to find and remove the first lymph node (sentinel node) that cancer might spread to, to stage vulvar cancer more accurately. It's for patients with a smaller tumor (under 4 cm) that hasn't been treated in the groin area before.
This trial compares two ways to check for cancer spread in the groin: a less invasive ultrasound scan versus surgery to remove lymph nodes. The goal is to see if the scan is just as safe and can help avoid extra surgery.
This study compares two methods for finding the first lymph node (sentinel node) that may contain cancer in people with vulvar cancer. It uses a dye called indocyanine green alone or with a radioactive tracer (technetium) to see which approach works better for staging the disease.
This study is testing a new imaging tracer (a substance that helps see cancer on scans) on tissue samples from people with vulvar cancer. It aims to see if this tracer can help better identify cancer cells.
Hear when a new Recurent Vulvar Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.